220 related articles for article (PubMed ID: 22888204)
1. Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy.
McCorquodale T; Lahooti H; Gopinath B; Wall JR
Clin Ophthalmol; 2012; 6():1063-71. PubMed ID: 22888204
[TBL] [Abstract][Full Text] [Related]
2. Eye findings and immunological markers in probands and their euthyroid relatives from a single family with multiple cases of thyroid autoimmunity.
Ardley M; McCorquodale T; Lahooti H; Champion B; Wall JR
Thyroid Res; 2012 Jun; 5(1):4. PubMed ID: 22742084
[TBL] [Abstract][Full Text] [Related]
3. Eye signs and serum eye muscle and collagen XIII antibodies in patients with transient and progressive thyroiditis.
Gopinath B; Ma G; Wall JR
Thyroid; 2007 Nov; 17(11):1123-9. PubMed ID: 17887926
[TBL] [Abstract][Full Text] [Related]
4. [Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].
Wall JR; Lahooti H
Endokrynol Pol; 2011; 62 Suppl 1():1-7. PubMed ID: 22125104
[TBL] [Abstract][Full Text] [Related]
5. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
[TBL] [Abstract][Full Text] [Related]
6. Relationship between smoking and serum levels of eye muscle and orbital connective tissue antibodies in patients with Graves ophthalmopathy.
Lahooti H; Champion B; Wall JR
Endocrine; 2023 Mar; ():. PubMed ID: 36905575
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?
Wall JR; Lahooti H
Endokrynol Pol; 2010; 61(2):222-7. PubMed ID: 20464711
[TBL] [Abstract][Full Text] [Related]
8. Thyroid-stimulating immunoglobulins as measured in a reporter bioassay are not detected in patients with Hashimoto's thyroiditis and ophthalmopathy or isolated upper eyelid retraction.
Wall JR; Lahooti H; El Kochairi I; Lytton SD; Champion B
Clin Ophthalmol; 2014; 8():2071-6. PubMed ID: 25336908
[TBL] [Abstract][Full Text] [Related]
9. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
11. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
[TBL] [Abstract][Full Text] [Related]
12. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction.
Gopinath B; Adams CL; Musselman R; Tani J; Wall JR
Ocul Immunol Inflamm; 2007; 15(2):81-8. PubMed ID: 17558832
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves' disease.
Suzuki N; Noh JY; Kameda T; Yoshihara A; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Iwaku K; Watanabe N; Mukasa K; Kozaki A; Inoue T; Sugino K; Ito K
Clin Ophthalmol; 2018; 12():739-746. PubMed ID: 29719374
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?
Lahooti H; Parmar KR; Wall JR
Clin Ophthalmol; 2010 May; 4():417-25. PubMed ID: 20505833
[TBL] [Abstract][Full Text] [Related]
16. Correlation between thyroidal and peripheral blood total T cells, CD8
Al-Ansari F; Lahooti H; Stokes L; Edirimanne S; Wall J
Endocr Res; 2018 Nov; 43(4):264-274. PubMed ID: 29787340
[TBL] [Abstract][Full Text] [Related]
17. Thyroid antibody-negative euthyroid Graves' ophthalmopathy.
Tabasum A; Khan I; Taylor P; Das G; Okosieme OE
Endocrinol Diabetes Metab Case Rep; 2016; 2016():160008. PubMed ID: 27284451
[TBL] [Abstract][Full Text] [Related]
18. Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy.
De Bellis A; Bizzarro A; Conte M; Coronella C; Solimeno S; Perrino S; Sansone D; Guaglione M; Wall JR; Bellastella A
Clin Endocrinol (Oxf); 2003 Sep; 59(3):388-95. PubMed ID: 12919164
[TBL] [Abstract][Full Text] [Related]
19. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
[TBL] [Abstract][Full Text] [Related]
20. Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.
Woo YJ; Jang SY; Lim TH; Yoon JS
Korean J Ophthalmol; 2015 Aug; 29(4):213-9. PubMed ID: 26240504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
